Clinical Trials Directory

Trials / Completed

CompletedNCT05924763

The Clinical Outcome of BiCRI in the Treatment of Chondral and Osteochondral Lesions

The Clinical Outcome of the Biphasic Cartilage Repair Implant (BiCRI) in the Treatment of Chondral and Osteochondral Lesions of the Knee.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
BioGend Therapeutics Co.Ltd · Industry
Sex
All
Age
16 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Based on the previous successful experiences, the investigators like to extend our patient population. In this study, the investigators aim to determine the safety and effectiveness of the Biphasic Cartilage Repair Implant (BiCRI) in the treatment of chondral and osteochondral lesions of the knee, including but not limited to more than one (1) lesion and the lesion that had been treated with microfracture or mosaicplasty but failed.

Detailed description

Patients who qualify for this trial and who are interested in participating will be consented using an Institutional Review Board (IRB) approved Informed Consent. Once a patient has signed the Informed Consent Form he/she is considered enrolled in the trial. If during surgery the size of lesion is found to meet exclusion criteria, the subject will be considered withdrawn (screen failure) from the trial. Clinical trial eligibility should be determined by confirmation that the patient meets the criteria included in the Protocol. Standard arthroscopic technique should be used to fully assess the joint and determine if the chondral or osteochondral defect is appropriate for inclusion in the study. Through arthroscopic examination after initial debridement, the investigator should use his best judgment to estimate the size of the lesion, and the number of BiCRI to be applied. Plain radiographs and MRI prior to 6-month (inclusive) visit will be performed according to routine clinical practice; however, 12-month and 24-monthpostoperative images should be done for study outcome evaluation

Conditions

Interventions

TypeNameDescription
DEVICEBiphasic Cartilage Repair Implant (BiCRI)The Biphasic Cartilage Repair Implant (BiCRI) is a two-phase scaffold composed of poly(lactic-co-glycolic acid) (PLGA) and β-triCalcium phosphate (TCP).

Timeline

Start date
2019-05-20
Primary completion
2022-06-10
Completion
2022-08-18
First posted
2023-06-29
Last updated
2025-09-25

Locations

2 sites across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT05924763. Inclusion in this directory is not an endorsement.